We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Signet Jewelers
SIG
$4.53B
| $3.75M | 0.07% |
27,000
-1,835
| -6% | -$227K |
2013 Q2
7 quarters
|
|
152
Kinder Morgan
KMI
$73.1B
| $3.74M | 0.07% |
88,979
-1,931
| -2% | -$80K |
2014 Q4
1 quarter
|
|
153
DELISTED
Du Pont De Nemours E I
DD
| $3.63M | 0.07% |
53,433
-926
| -2% | -$66.1K |
2013 Q2
7 quarters
|
|
154
Aemetis
AMTX
$105M
| $3.55M | 0.06% |
842,168
+104,708
| +14% | +$454K |
2014 Q2
3 quarters
|
|
155
Wells Fargo
WFC
$248B
| $3.52M | 0.06% |
64,690
+265
| +0.4% | +$14.3K |
2013 Q2
7 quarters
|
|
156
Chevron
CVX
$430B
| $3.34M | 0.06% |
31,812
-1,893
| -6% | -$202K |
2013 Q2
7 quarters
|
|
157
3M
MMM
$85.3B
| $3.32M | 0.06% |
24,079
-642
| -3% | -$88.5K |
2013 Q2
7 quarters
|
|
|
NORD
158
DELISTED
Nord Anglia Education, Inc.
NORD
| $3.32M | 0.06% |
146,003
-26,870
| -16% | -$555K |
2014 Q1
4 quarters
|
|
159
AT&T
T
$161B
| $3.27M | 0.06% |
132,577
-5,318
| -4% | -$135K |
2013 Q2
7 quarters
|
|
160
iShares MSCI Emerging Markets ETF
EEM
$29.6B
| $3.27M | 0.06% |
81,393
-1,708
| -2% | -$67.9K |
2013 Q2
7 quarters
|
|
161
SPDR Gold Trust
GLD
$142B
| $3.17M | 0.06% |
27,873
-3,968
| -12% | -$464K |
2013 Q2
7 quarters
|
|
|
NGLS
162
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
| $3.15M | 0.06% |
76,113
-852
| -1% | -$37.4K |
2013 Q2
7 quarters
|
|
163
Toyota
TM
$226B
| $2.99M | 0.05% |
21,406
+11,706
| +121% | +$1.56M |
2014 Q4
1 quarter
|
|
|
164
Accenture
ACN
$138B
| $2.99M | 0.05% |
31,914
-416,886
| -93% | -$37.2M |
2013 Q2
7 quarters
|
|
165
Copa Holdings
CPA
$5.47B
| $2.99M | 0.05% |
29,574
-1,791
| -6% | -$194K |
2013 Q2
7 quarters
|
|
|
TRIB
166
Trinity Biotech
TRIB
$6.45M
| $2.98M | 0.05% |
1,033
-117
| -10% | -$324K |
2013 Q2
7 quarters
|
|
167
MPLX
MPLX
$57.9B
| $2.95M | 0.05% |
40,305
+3,505
| +10% | +$266K |
2014 Q1
4 quarters
|
|
|
CEB
168
DELISTED
CEB Inc.
CEB
| $2.93M | 0.05% |
36,658
+7,386
| +25% | +$556K |
2013 Q2
7 quarters
|
|
169
Equinor
EQNR
$106B
| $2.86M | 0.05% |
162,460
+67,702
| +71% | +$1.21M |
2014 Q2
3 quarters
|
|
170
Honeywell
HON
$66.7B
| $2.79M | 0.05% |
29,782
+2
| +0% | +$183 |
2013 Q2
7 quarters
|
|
171
Philip Morris
PM
$312B
| $2.78M | 0.05% |
36,860
+141
| +0.4% | +$11.4K |
2013 Q2
7 quarters
|
|
172
Baxter International
BAX
$13.3B
| $2.77M | 0.05% |
74,446
-2,112
| -3% | -$80.1K |
2013 Q2
7 quarters
|
|
|
FNGN
173
DELISTED
Financial Engines, Inc.
FNGN
| $2.76M | 0.05% |
66,013
+345
| +0.5% | +$13.6K |
2013 Q2
7 quarters
|
|
174
Televisa
TV
$1.29B
| $2.74M | 0.05% |
83,055
-17,063
| -17% | -$574K |
2013 Q4
5 quarters
|
|
|
PSXP
175
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $2.7M | 0.05% |
38,255
+3,665
| +11% | +$263K |
2014 Q1
4 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.